Shiga toxin-producing Escherichia coli O84 isolates (n ‫؍‬ 22) were examined using culture-and molecularly based methods in order to compare their phenotypic and genotypic characteristics. These analyses directly linked Shiga toxin-producing Escherichia coli O84 isolates from cattle and sheep with human isolates indicating that New Zealand livestock may be a reservoir of infection.
The first recorded case in New Zealand of Shiga toxinproducing Escherichia coli (STEC) O157:H7 was in 1993 (3), and since then, STEC strains, including O157, have been isolated from sporadic cases of infection in increasing numbers, reaching a maximum of 91 cases (88 O157 and 3 non-O157) isolates in 2003 (1) . Within New Zealand, over 90% of STEC strains detected from human clinical cases are serogroup O157, but whether this is a true reflection of most STEC infections being associated with O157 or whether this is a consequence of screening methods is unknown. Recent investigations detected only non-O157 STEC strains, such as O5, O26, O84, O91, and O128) from New Zealand cattle and sheep (7, 8) . In this report, we outline the emergence of serogroup O84 as a causative agent of diarrheal disease in New Zealand, its source, its phenotypic and genotypic analysis, and comparison with several O84 isolates obtained overseas. Twenty-two STEC O84 isolates were examined in this study. Of these, nine O84:HϪ/H2 strains were isolated from cattle and two O84:HϪ strains were isolated from sheep (7, 8) . Four bovine isolates from Scotland (10), two bovine isolates from Germany (11), and five human clinical O84 isolates from New Zealand were also included in the study (Table 1) . In contrast to the 16 New Zealand O84 isolates that were non-sorbitol fermenting (NSF) and ␤-glucuronidase negative, the four Scottish isolates and IHIT3669 were sorbitol fermenting (SF) and ␤-glucuronidase negative ( Table 1 ). The remaining German isolate, 537/89, was positive for SF and ␤-glucuronidase positive (Table 1) .
stx and/or eae detection was performed using a multiplex PCR method outlined previously (6) . Primers intF and (zeta) intR, based on GenBank sequence AJ298279 from STEC O84 537/89 (11), were used to detect the eae subtype. The STEC enterohemolysin (ehxA), serine protease (espP), katalase peroxidase (katP), and type II secretion system (etpD) genes were detected using primers outlined previously (5, 6, 12) . PCR analysis indicated that all 22 of the isolates were stx 1 , eae ( subtype), ehxA, and espP positive (Table 1) .
Plasmids were isolated and digested with BamHI or EcoRI to compare plasmid profiles and Southern blot analysis was performed using a 534-bp fragment from the ehxA locus from E. coli O157:H7 (NCTC12900) as a probe against EcoRI-cut plasmid DNA that was transferred to a nylon membrane. Nine distinctive BamHI plasmid digest profiles and seven distinctive EcoRI plasmid digest profiles were observed (Fig. 1) . The New Zealand O84 isolates could be grouped into at least four EcoRI plasmid profile types although profiles A and B could be readily distinguished only through extended electrophoresis (data not shown). The STEC ehxA probe hybridized to a single EcoRI fragment of approximately 6.8 kb in 14 of 15 New Zealand isolates (Fig. 1c ) but hybridized to a fragment of approximately 10-kb associated with 02-2853.
Pulse-field gel electrophoresis (PFGE) of the 22 O84 isolates was performed using the PulseNet standardized protocol (2) . Sixteen different PFGE profiles were identified among the 22 O84 isolates. Although the PFGE pattern E derived from a bovine O84 isolate, AGR133, was indistinguishable from that of the human isolate 02-2853 (Fig. 2) and their BamHI plasmid digest profiles were relatively similar (Fig. 1a) , the 02-2853 EcoRI plasmid digest profile differed from that of AGR133 by an insertion of approximately 3 kb in the corresponding 7.2-kb band (Fig. 1b) .
The apparent significance in the isolation of five STEC O84 isolates from cases of human illness in New Zealand over a period of approximately three years led us to examine whether there were any phenotypic or genotypic links between the STEC O84 samples recently isolated from cattle and sheep (8) . While O84:HϪ has been associated with diarrhea and/or hemolytic-uremic syndrome in Germany (9, 13) and Spain (4), disease associated with the O84:H2 serotype has not been recorded. STEC O84 has been isolated worldwide, mainly from healthy cattle in Canada, Belgium, Germany, Japan, France, Hong Kong, United Kingdom, the United States, and Australia but also from cattle with diarrhea and from healthy sheep (www.microbionet.com.au/vtecfullref1u.htm), indicating that healthy cattle and sheep are a reservoir for STEC O84 worldwide. The worldwide distribution of the NSF, ␤-glucuronidase-negative clone resistant to cefixime and tellurite is unknown, but none of the overseas isolates had this phenotype. The cefixime-and tellurite-resistant, NSF, ␤-glucuronidasenegative phenotype, typical of the New Zealand O84 isolates may be a factor in their comparative frequency of isolation from recent human diarrheal cases in New Zealand. In contrast, the apparent rarity of the O84 serogroup as a potential causative agent of diarrheal disease in Europe and the rest of the world may be due to its ability to ferment sorbitol, a trait that may be overlooked when the focus is upon NSF STEC strains such as O157:H7. In this study, however, we have been able to examine only sorbitol fermentation of six non-New Zealand O84 isolates. PFGE has been proven as a powerful tool for the epidemiological analysis of bacterial isolates isolated from human disease and comparison with isolates from animals or from the environment through visualization of the whole bacterial genome and provides a high degree of discrimination within STEC serogroups. This study, besides linking an , it is important to be aware that non-sorbitol fermenting, ␤-glucuronidase-negative isolates that are also resistant to cefixime and tellurite, and that do not react with anti-E. coli O157 antisera or latex reagent, should be assessed for the presence of stx and other associated virulence factors in order to preclude non-O157 STEC infection. In summary, this is the first study to note the apparent link between STEC O84 from cattle and sheep with human disease through PFGE analysis; however, the actual routes of transmission and the minimal infectious dose for disease to occur are unknown. Therefore, further focus is required to evaluate the significance of STEC O84 as a cause of human disease both in New Zealand and worldwide and to establish its pathogenic mechanisms.
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